| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0038 | 1 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.0059 | 1 |